Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase 3 randomized trial. Haematologica Ghia, P., Coutre, S. E., Cheson, B. D., Barrientos, J. C., Hillmen, P., Pettitt, A. R., Zelenetz, A. D., Shreay, S., Hallek, M., Furman, R. R. 2020

View details for DOI 10.3324/haematol.2019.238808

View details for PubMedID 32054652